论文部分内容阅读
目的探讨复方甘露醇联合利多卡因治疗颅内高压症的疗效。方法将2010年2月-2012年3月期间我院收治的颅内高压患者134例随机分为观察组与对照组各67例,所有患者均接受针对原发疾病的治疗,观察组患者再接受复方甘露醇联合利多卡因治疗,对照组患者再接受复方甘露醇治疗。结果①观察组治疗前后颅压的降低幅度显著大于对照组,两组患者比较差异有统计学意义(P<0.05)。②观察组治疗效果显著优于对照组,两组患者比较差异有统计学意义(P<0.05)。结论复方甘露醇联合利多卡因治疗颅内高压症的疗效确切,该联合方案可作为临床上治疗颅内高压症的常规方法之一。
Objective To investigate the curative effect of compound mannitol and lidocaine on patients with intracranial hypertension. Methods 134 patients with intracranial hypertension treated in our hospital from February 2010 to March 2012 were randomly divided into observation group (67 cases) and control group (67 cases), all patients were treated for primary disease, and patients in observation group were re-accepted Compound mannitol combined lidocaine treatment, patients in the control group and then received compound mannitol treatment. Results ① The decrease of intracranial pressure in observation group before and after treatment was significantly greater than that in control group. There was significant difference between the two groups (P <0.05). ② The observation group was significantly better than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion The combination of mannitol and lidocaine is effective in the treatment of intracranial hypertension. The combined regimen can be used as one of the routine methods for the treatment of intracranial hypertension.